
Terumo Corp (4543) - Product Pipeline Analysis, 2022 Update
Description
Summary
Terumo Corp (Terumo) is a medical technology company that manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, medical electronic, peritoneal dialysis, and digital thermometers. The company’s systems find applications in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through subsidiaries and associate companies in Japan, China, Europe, North America, South America, Asia Pacific, the Middle East and Africa. Terumo is headquartered in Tokyo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Terumo Corp (Terumo) is a medical technology company that manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, medical electronic, peritoneal dialysis, and digital thermometers. The company’s systems find applications in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through subsidiaries and associate companies in Japan, China, Europe, North America, South America, Asia Pacific, the Middle East and Africa. Terumo is headquartered in Tokyo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Terumo Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
110 Pages
- Terumo Corp Company Overview
- Terumo Corp Company Snapshot
- Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview
- Terumo Corp – Pipeline Analysis Overview
- Business Description
- Terumo Corp - Key Facts
- Terumo Corp - Major Products and Services
- Terumo Corp Pipeline Products by Development Stage
- Terumo Corp Ongoing Clinical Trials by Trial Status
- Terumo Corp Pipeline Products Overview
- Advanced Coil
- Advanced Coil Product Overview
- Advanced WEB Aneurysm Embolization Device
- Advanced WEB Aneurysm Embolization Device Product Overview
- AI-Based Percutaneous Coronary Intervention System
- AI-Based Percutaneous Coronary Intervention System Product Overview
- AortaFit System
- AortaFit System Product Overview
- AortaFit System Clinical Trial
- Atherectomy Device
- Atherectomy Device Product Overview
- Automated Injection Device
- Automated Injection Device Product Overview
- Balloon Guide Catheter
- Balloon Guide Catheter Product Overview
- BoulEVARd Stent
- BoulEVARd Stent Product Overview
- CAPIOX NX19 Oxygenator
- CAPIOX NX19 Oxygenator Product Overview
- CMOS Image Glucose Sensor
- CMOS Image Glucose Sensor Product Overview
- Coated Stent
- Coated Stent Product Overview
- Coil Assist Stent
- Coil Assist Stent Product Overview
- Cross-Seal System
- Cross-Seal System Product Overview
- Digital Healthcare Support System
- Digital Healthcare Support System Product Overview
- Digital Therapy Support System
- Digital Therapy Support System Product Overview
- Fineglide
- Fineglide Product Overview
- Flash PTCA
- Flash PTCA Product Overview
- Flow Diverter
- Flow Diverter Product Overview
- Hybrid Stent Graft
- Hybrid Stent Graft Product Overview
- Infusion Pump
- Infusion Pump Product Overview
- Izanai
- Izanai Product Overview
- Kaitoh
- Kaitoh Product Overview
- Kenma
- Kenma Product Overview
- Large Volume Injector
- Large Volume Injector Product Overview
- Liver Cancer Ablation System
- Liver Cancer Ablation System Product Overview
- Mirasol Pathogen Reduction Technology System - Platelets & Plasma
- Mirasol Pathogen Reduction Technology System - Platelets & Plasma Product Overview
- Mirasol Pathogen Reduction Technology System - Whole Blood
- Mirasol Pathogen Reduction Technology System - Whole Blood Product Overview
- Nesaku
- Nesaku Product Overview
- Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold
- Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold Product Overview
- Next Ultimaster Metallic Drug Eluting Stent
- Next Ultimaster Metallic Drug Eluting Stent Product Overview
- Non-Contact Data Link Thermometer
- Non-Contact Data Link Thermometer Product Overview
- Ophthalmic Needle
- Ophthalmic Needle Product Overview
- Optimal Dosing System
- Optimal Dosing System Product Overview
- Opuswave
- Opuswave Product Overview
- Peripheral Embolization Coil
- Peripheral Embolization Coil Product Overview
- Plasmapheresis Device
- Plasmapheresis Device Product Overview
- Plastic Needle
- Plastic Needle Product Overview
- QuiremSpheres
- QuiremSpheres Product Overview
- QuiremSpheres Clinical Trial
- QuiremSpheres - Brain Tumor
- QuiremSpheres - Brain Tumor Product Overview
- QuiremSpheres - Pancreatic Tumor
- QuiremSpheres - Pancreatic Tumor Product Overview
- QuiremSpheres - Pancreatic Tumor Clinical Trial
- Radial Access Closure Device
- Radial Access Closure Device Product Overview
- RelayBranch Thoracic Stent-Graft System
- RelayBranch Thoracic Stent-Graft System Product Overview
- RelayBranch Thoracic Stent-Graft System Clinical Trial
- RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection
- RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Product Overview
- RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Clinical Trial
- RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury
- RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury Product Overview
- Renal Sympathetic Denervation System - TRI Technique
- Renal Sympathetic Denervation System - TRI Technique Product Overview
- Robotic Surgical Support
- Robotic Surgical Support Product Overview
- Runner PTCA Balloon Catheter
- Runner PTCA Balloon Catheter Product Overview
- Runner Slim PTCA
- Runner Slim PTCA Product Overview
- Small Size Syringe Pump
- Small Size Syringe Pump Product Overview
- Smartphone-Type Device - MEDISAFE WITH
- Smartphone-Type Device - MEDISAFE WITH Product Overview
- Structural Heart Disease Device
- Structural Heart Disease Device Product Overview
- SURFLASH Safety I.V. Catheter
- SURFLASH Safety I.V. Catheter Product Overview
- TERUMO Surshield-PUR Safety I.V. Catheter
- TERUMO Surshield-PUR Safety I.V. Catheter Product Overview
- TF Press
- TF Press Product Overview
- Thoracoabdominal Hybrid Device
- Thoracoabdominal Hybrid Device Product Overview
- TREOVANCE Abdominal Stent Graft With Navitel Delivery System
- TREOVANCE Abdominal Stent Graft With Navitel Delivery System Product Overview
- TREOVANCE Abdominal Stent Graft With Navitel Delivery System Clinical Trial
- ULTIMASTER NAGOMI
- ULTIMASTER NAGOMI Product Overview
- Ultimaster Tansei
- Ultimaster Tansei Product Overview
- Ultimaster Tansei Clinical Trial
- Wrist Artery Guidewire
- Wrist Artery Guidewire Product Overview
- Terumo Corp - Key Competitors
- Terumo Corp - Key Employees
- Terumo Corp - Key Employee Biographies
- Terumo Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Terumo Corp, Recent Developments
- Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
- Oct 21, 2021: Terumo Blood and Cell Technologies opens manufacturing facility in Costa Rica
- Oct 07, 2021: Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing
- Sep 09, 2021: Etiometry and Terumo Cardiovascular announce partnership to deliver enhanced monitoring insights for adult cardiac surgery patients
- Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
- Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
- Jul 19, 2021: Terumo and UMCU strengthen their partnership to develop solutions in Interventional OncologyTerumo Europe and University Medical Center Utrecht signed a memorandum of understanding
- Jun 08, 2021: Terumo Blood and Cell Technologies joins Cell and Gene Therapy Catapult Process Analytical Technology (PAT) Consortium
- May 13, 2021: Terumo donates additional USD 1 million to support the COVID-19 solidarity response fund for WHO
- Mar 31, 2021: Terumo begins production of FN syringe syringe for drug administration
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Terumo Corp Pipeline Products by Equipment Type
- Table 3: Terumo Corp Pipeline Products by Indication
- Table 4: Terumo Corp, Key Facts
- Table 5: Terumo Corp, Major Products and Services
- Table 6: Terumo Corp Number of Pipeline Products by Development Stage
- Table 7: Terumo Corp Pipeline Products Summary by Development Stage
- Table 8: Terumo Corp Ongoing Clinical Trials by Trial Status
- Table 9: Terumo Corp Ongoing Clinical Trials Summary
- Table 10: Advanced Coil - Product Status
- Table 11: Advanced Coil - Product Description
- Table 12: Advanced WEB Aneurysm Embolization Device - Product Status
- Table 13: Advanced WEB Aneurysm Embolization Device - Product Description
- Table 14: AI-Based Percutaneous Coronary Intervention System - Product Status
- Table 15: AI-Based Percutaneous Coronary Intervention System - Product Description
- Table 16: AortaFit System - Product Status
- Table 17: AortaFit System - Product Description
- Table 18: AortaFit System - Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study
- Table 19: Atherectomy Device - Product Status
- Table 20: Atherectomy Device - Product Description
- Table 21: Automated Injection Device - Product Status
- Table 22: Automated Injection Device - Product Description
- Table 23: Balloon Guide Catheter - Product Status
- Table 24: Balloon Guide Catheter - Product Description
- Table 25: BoulEVARd Stent - Product Status
- Table 26: BoulEVARd Stent - Product Description
- Table 27: CAPIOX NX19 Oxygenator - Product Status
- Table 28: CAPIOX NX19 Oxygenator - Product Description
- Table 29: CMOS Image Glucose Sensor - Product Status
- Table 30: CMOS Image Glucose Sensor - Product Description
- Table 31: Coated Stent - Product Status
- Table 32: Coated Stent - Product Description
- Table 33: Coil Assist Stent - Product Status
- Table 34: Coil Assist Stent - Product Description
- Table 35: Cross-Seal System - Product Status
- Table 36: Cross-Seal System - Product Description
- Table 37: Digital Healthcare Support System - Product Status
- Table 38: Digital Healthcare Support System - Product Description
- Table 39: Digital Therapy Support System - Product Status
- Table 40: Digital Therapy Support System - Product Description
- Table 41: Fineglide - Product Status
- Table 42: Fineglide - Product Description
- Table 43: Flash PTCA - Product Status
- Table 44: Flash PTCA - Product Description
- Table 45: Flow Diverter - Product Status
- Table 46: Flow Diverter - Product Description
- Table 47: Hybrid Stent Graft - Product Status
- Table 48: Hybrid Stent Graft - Product Description
- Table 49: Infusion Pump - Product Status
- Table 50: Infusion Pump - Product Description
- Table 51: Izanai - Product Status
- Table 52: Izanai - Product Description
- Table 53: Kaitoh - Product Status
- Table 54: Kaitoh - Product Description
- Table 55: Kenma - Product Status
- Table 56: Kenma - Product Description
- Table 57: Large Volume Injector - Product Status
- Table 58: Large Volume Injector - Product Description
- Table 59: Liver Cancer Ablation System - Product Status
- Table 60: Liver Cancer Ablation System - Product Description
- Table 61: Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Status
- Table 62: Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Description
- Table 63: Mirasol Pathogen Reduction Technology System - Whole Blood - Product Status
- Table 64: Mirasol Pathogen Reduction Technology System - Whole Blood - Product Description
- Table 65: Nesaku - Product Status
- Table 66: Nesaku - Product Description
- Table 67: Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold - Product Status
- Table 68: Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold - Product Description
- Table 69: Next Ultimaster Metallic Drug Eluting Stent - Product Status
- Table 70: Next Ultimaster Metallic Drug Eluting Stent - Product Description
- Table 71: Non-Contact Data Link Thermometer - Product Status
- Table 72: Non-Contact Data Link Thermometer - Product Description
- Table 73: Ophthalmic Needle - Product Status
- Table 74: Ophthalmic Needle - Product Description
- Table 75: Optimal Dosing System - Product Status
- Table 76: Optimal Dosing System - Product Description
- Table 77: Opuswave - Product Status
- Table 78: Opuswave - Product Description
- Table 79: Peripheral Embolization Coil - Product Status
- Table 80: Peripheral Embolization Coil - Product Description
- Table 81: Plasmapheresis Device - Product Status
- Table 82: Plasmapheresis Device - Product Description
- Table 83: Plastic Needle - Product Status
- Table 84: Plastic Needle - Product Description
- Table 85: QuiremSpheres - Product Status
- Table 86: QuiremSpheres - Product Description
- Table 87: QuiremSpheres - Clinical Validation of a Fractional Administration Device for Holmium-166 Microspheres During Selective Internal Radiation Therapy in Patients With Liver Tumours
- Table 88: QuiremSpheres - Holmium-166 Retrospective Collection of Real-World Data
- Table 89: QuiremSpheres - Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma; a Prospective, Single-arm, Open Label, Multicenter Phase II Study: HOMIE-166
- Table 90: QuiremSpheres - Holmium-166-radioembolization in Patients with Unresectable Hepatocellular Carcinoma (HCC); a Multi-center, Interventional, Non-randomized, Non-comparative, Open Label, Early Phase II Study: HEPAR Primary
- Table 91: QuiremSpheres - Brain Tumor - Product Status
- Table 92: QuiremSpheres - Brain Tumor - Product Description
- Table 93: QuiremSpheres - Pancreatic Tumor - Product Status
- Table 94: QuiremSpheres - Pancreatic Tumor - Product Description
- Table 95: QuiremSpheres - Pancreatic Tumor - Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Center, Non-randomized, Feasibility Study in an Open Surgical Setting - The SLOTH1 Study
- Table 96: Radial Access Closure Device - Product Status
- Table 97: Radial Access Closure Device - Product Description
- Table 98: RelayBranch Thoracic Stent-Graft System - Product Status
- Table 99: RelayBranch Thoracic Stent-Graft System - Product Description
- Table 100: RelayBranch Thoracic Stent-Graft System - A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery
- Table 101: RelayBranch Thoracic Stent-Graft System - Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System
- Table 102: RelayBranch Thoracic Stent-Graft System - ENDOBARC-S Study: Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain" "
- Table 103: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Status
- Table 104: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Description
- Table 105: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - A Prospective, Multi-center, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection
- Table 106: RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Status
- Table 107: RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Description
- Table 108: Renal Sympathetic Denervation System - TRI Technique - Product Status
- Table 109: Renal Sympathetic Denervation System - TRI Technique - Product Description
- Table 110: Robotic Surgical Support - Product Status
- Table 111: Robotic Surgical Support - Product Description
- Table 112: Runner PTCA Balloon Catheter - Product Status
- Table 113: Runner PTCA Balloon Catheter - Product Description
- Table 114: Runner Slim PTCA - Product Status
- Table 115: Runner Slim PTCA - Product Description
- Table 116: Small Size Syringe Pump - Product Status
- Table 117: Small Size Syringe Pump - Product Description
- Table 118: Smartphone-Type Device - MEDISAFE WITH - Product Status
- Table 119: Smartphone-Type Device - MEDISAFE WITH - Product Description
- Table 120: Structural Heart Disease Device - Product Status
- Table 121: Structural Heart Disease Device - Product Description
- Table 122: SURFLASH Safety I.V. Catheter - Product Status
- Table 123: SURFLASH Safety I.V. Catheter - Product Description
- Table 124: TERUMO Surshield-PUR Safety I.V. Catheter - Product Status
- Table 125: TERUMO Surshield-PUR Safety I.V. Catheter - Product Description
- Table 126: TF Press - Product Status
- Table 127: TF Press - Product Description
- Table 128: Thoracoabdominal Hybrid Device - Product Status
- Table 129: Thoracoabdominal Hybrid Device - Product Description
- Table 130: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Product Status
- Table 131: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Product Description
- Table 132: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Anatomical Feasibility of an Off-the-shelf Scalloped Stent-graft for Infrarenal Abdominal Aneurysm with a Hostile Neck (ReSTHoNe Study)
- Table 133: ULTIMASTER NAGOMI - Product Status
- Table 134: ULTIMASTER NAGOMI - Product Description
- Table 135: Ultimaster Tansei - Product Status
- Table 136: Ultimaster Tansei - Product Description
- Table 137: Ultimaster Tansei - A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions
- Table 138: Ultimaster Tansei - Comparison of the Supraflex Cruz 60 Micron Stent Strut Versus the Ultimaster Tansei 80 Micron Stent Strut in High Bleeding Risk PCI Population
- Table 139: Ultimaster Tansei - Evaluation of Effectiveness and Safety of the First, Second, and New Drug-eluting Stents in Routine Clinical Practice
- Table 140: Ultimaster Tansei - Zotarolimus Eluting Stent Versus Sirolimus Eluting Stent in High Bleeding Risk Angioplasty
- Table 141: Wrist Artery Guidewire - Product Status
- Table 142: Wrist Artery Guidewire - Product Description
- Table 143: Terumo Corp, Key Employees
- Table 144: Terumo Corp, Key Employee Biographies
- Table 145: Terumo Corp, Other Locations
- Table 146: Terumo Corp, Subsidiaries
- Table 147: Glossary
- List of Figures
- Figure 1: Terumo Corp Pipeline Products by Equipment Type
- Figure 2: Terumo Corp Pipeline Products by Development Stage
- Figure 3: Terumo Corp Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.